Vamsi Labs Ltd. | Vamsi Pharma

The company provides integrated CDMO and CRO services, supporting partners from product development through commercial manufacturing and technology transfer.

Contract Manufacturing (CDMO)

Flexible, scalable, and regulatory-compliant manufacturing services include:

• Premix manufacturing compliant with IP, BP, and international pharmacopoeial standards.
• Large-scale production of bulk capsule formulations in certified manufacturing facilities.
• Finished dosage form (FDF) manufacturing, available as standalone dosage forms or as drug–device combination products.

The manufacturing facilities are designed to support highly regulated markets, including the United States and Europe.

Product Development (CRO)

Comprehensive development services include:

• Generic product development for US FDA, EMA, and global regulatory submissions.
• Development of novel and differentiated formulations with advanced drug delivery technologies.
• Regulatory support based on robust CMC expertise to accelerate approvals and commercialization.

Technology Transfer

End-to-end technology transfer services ensure a smooth transition from development to commercial manufacturing through:

• Process scale-up and validation.
• Preparation of technical documentation for global regulatory filings.
• Integration into commercial manufacturing networks while maintaining consistent product quality and performance.

Structured technology transfer protocols help minimize project risks, reduce development timelines, and ensure compliance with international regulatory standards.